Related Experiment Video

Updated: Jan 3, 2026

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.6K

Personalized Medicine in Gynecologic Cancer: Fact or Fiction?

Logan Corey1, Ana Valente1, Katrina Wade2

  • 1Department of Obstetrics and Gynecology, Ochsner Clinic Foundation, 2700 Napoleon Avenue, New Orleans, LA 70115, USA.

Surgical Oncology Clinics of North America
|November 24, 2019
PubMed

Insights

Personalized medicine in gynecologic oncology is advancing rapidly, driven by molecular data and new therapies like VEGF inhibitors. Gynecologic oncologists face challenges navigating these personalized approaches and increased patient access to genetic testing.

Area of Science:

  • Gynecologic Oncology
  • Molecular Oncology
  • Precision Medicine

Background:

  • Personalized medicine is transforming gynecologic oncology.
  • Advances in tumor profiling and large-scale molecular data (e.g., TCGA, NCI-Match) are key drivers.
  • Direct-to-consumer genetic testing is increasing patient engagement in cancer care.

Purpose of the Study:

  • To review the current landscape of personalized medicine in gynecologic oncology.
  • To discuss novel targeted therapies and immunotherapies.
  • To highlight challenges and opportunities for clinicians.

Main Methods:

  • Literature review of recent advancements in personalized gynecologic oncology.
  • Discussion of targeted therapies including VEGF inhibitors and PARP inhibitors.
  • Exploration of cancer vaccines and the impact of genetic testing.

Main Results:

  • Several novel therapies targeting specific molecular alterations are emerging.
  • Increased patient access to genetic testing influences cancer care decisions.
  • The integration of personalized medicine requires adaptation by healthcare providers.

Conclusions:

  • Personalized medicine offers significant potential to improve outcomes in gynecologic oncology.
  • Navigating the complexities of molecular data and targeted therapies is crucial for clinicians.
  • Future directions involve integrating genetic insights into routine clinical practice.
Keywords:
Gynecologic malignanciesPersonalized medicinePrecision medicineTargeted therapies

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.6K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K